Biosplice Therapeutics
Health. Valued at $12bn (April 2021).
About
Biosplice Therapeutics is a tech company based in United States. Health. Valued at $12bn (April 2021). Its last reported valuation was $12bn (April 2021).
Founders
Osman Kibar
Facts
- Country
- United States
- Valuation
- $12bn (April 2021)
- Industry
- Health
- Stage
- Unicorn
- AI-native
- No
Is this your company?
Claim this profile
Free and instant: prove you run the company website and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Biosplice Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
For your website
A rank card with Biosplice Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.